ARTICLE | Financial News
Neurocrine files for follow-on
October 4, 2000 7:00 AM UTC
NBIX, a developer of therapeutics to treat neurological disorders, filed to sell 3 million shares in a follow-on underwritten by Robertson Stephens; and Salomon Smith Barney. The offering has a 450,00...